• News
  • SAN DIEGO
  • Medical

Amgen, Illumina team on personalized medicine test

Biotech drugmaker Amgen and Illumina, a maker of genetic testing equipment, said Wednesday they are developing a test that will identify patients who might be helped by Amgen's colon cancer drug Vectibix.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
189.97
  2.68  
+ 1.43%
1,469,849,000
197.37
102.30

Insider Trade Data

Date Insider Shares Type Value
12/16/2014 Walt, David R 12,000 Sell $2,198,990
12/15/2014 Stapley, Marc A 1,422 Sell $257,504
12/15/2014 Stapley, Marc A 1,422 Exchange $51,619
12/11/2014 Flatley, Jay T 25,000 Sell $4,644,803
12/11/2014 Flatley, Jay T 25,000 Exchange $501,000

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
SIC - 3826 - LABORATORY ANALYTICAL INSTRUMENTS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!